IIT Madras study shows efficacy of non-steroidal drug in Covid treatment

Widely used since 1960s as an anti-inflammatory formulation, Indomethacin also works as an antiviral agent in mild and moderate Covid-19 cases

A study conducted by a team of experts from IIT-Madras has shown ‘excellent efficacy’ of Indomethacin, a non-steroidal anti-inflammatory drug, as an antiviral agent in the treatment of mild and moderate COVID-19 patients.

Indomethacin, with more than two million prescriptions per year in the US alone, is an established drug widely used since the 1960s to treat various types of inflammation-related diseases. The Indian researchers are the first to show the efficacy of indomethacin through a randomised clinical trial though the scientific basis. The entire study was funded by Kris Gopalakrishnan an alumnus of IIT Madras and Chairman of Axilor Ventures.

The